FOXM1:一种新的治疗点,用于乳腺外帕杰特病
Takamichi Ito1, Yuka Tanaka2, Yumiko Kaku-Ito2
1Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. ito.takamichi.657@m.kyushu-u.ac.jp.
Scientific reports
|February 20, 2024
概括
这项研究揭示了叉盒M1 (FOXM1) 在乳腺外帕杰特病 (EMPD) 中表达很高,并且与生存率较差有关. 抑制FOXM1显示出作为EMPD患者新治疗策略的希望.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
背景情况:
- 乳外帕杰特病 (EMPD) 是一种罕见的皮肤癌,晚期的治疗选择有限.
- 转移性EMPD带来了不良的预后,凸显了需要新的治疗点的需要.
研究的目的:
- 调查分叉箱M1 (FOXM1) 在EMPD病变发生过程中的作用.
- 评估FOXM1作为乳腺外帕杰特病的潜在治疗点.
主要方法:
- 在112个原发性和17个转移性EMPD样本上进行了免疫组织化学检查.
- 在体外研究中使用了一种新建立的EMPD细胞系 (KS-EMPD-1),具有FOXM1敲击和列抑制.
主要成果:
- FOXM1表达与瘤进展相关,并且与较短的疾病特异性存活率显著相关.
- 在EMPD细胞系中观察到高FOXM1表达,其抑制降低了瘤细胞的活力,迁移和入侵.
- 提奥斯特普顿治疗以剂量依赖的方式抑制了EMPD细胞活力.
结论:
- 在EMPD的进展中,FOXM1发挥着重要作用.
- 向FOXM1代表了对乳腺外帕杰特病的有前途的治疗策略.
相关概念视频
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


